-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Sernova Biotherapeutics, Maintains C$1 Price Target

Benzinga·09/14/2026 12:27:48
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis reiterates Sernova Biotherapeutics (TSX:SVA) with a Buy and maintains C$1 price target.